Page last updated: 2024-12-10
arachidoyl-coenzyme a
Description
icosanoyl-CoA : A very long-chain fatty acyl-CoA that is the S-icosanoyl derivative of coenzyme A. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 3081439 |
| CHEBI ID | 15527 |
| SCHEMBL ID | 6006438 |
| MeSH ID | M0124608 |
Synonyms (30)
| Synonym |
|---|
| coenzyme a, s-eicosanoate |
| 3'-phosphoadenosine 5'-(3-{(3r)-3-hydroxy-4-[(3-{[2-(icosanoylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-2,2-dimethyl-4-oxobutyl} dihydrogen diphosphate) |
| CHEBI:15527 |
| C02041 |
| icosanoyl-coa |
| arachidoyl-coa |
| eicosanoyl-coa |
| coenzyme a, arachidoyl- |
| arachidoyl-coenzyme a |
| 15895-27-9 |
| s-[2-[3-[[(2r)-4-[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] icosanethioate |
| eicosanoyl coenzyme a |
| SCHEMBL6006438 |
| arachidoyl coenzyme a |
| LMFA07050329 |
| eicosyl-coenzyme a |
| eicosanethioic acid s-ester with coenzyme a |
| eicosanethioic acid |
| arachidyl coenzyme a |
| arachidyl coa |
| arachidinoyl-coenzyme a |
| s-eicosanoate |
| arachidinoyl-coa |
| s-eicosanoic acid |
| eicosanethioate |
| s-eicosanoate coa |
| s-eicosanoate coenzyme a |
| Q27098079 |
| 3IX , |
| DTXSID601317430 |
Roles (1)
| Role | Description |
|---|
| human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| long-chain fatty acyl-CoA | A fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of any long-chain (C13 to C22) fatty acid. |
| 11,12-saturated fatty acyl-CoA | Any fatty acyl-CoA in which the 11-12 bond of the fatty acyl group is saturated. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.17
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.17 (24.57) | | Research Supply Index | 2.20 (2.92) | | Research Growth Index | 4.36 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |